In this episode we will discuss AliveCor announced Thursday, July 8 it received 510(k) clearance by the U.S. Food and Drug Administration for healthcare professionals to use the KardiaMobile 6L device to calculate patients’ QTc interval. We will talk about the Kardia device and explain why this new announcement is important to those who have an interest in their heart health. More info on the device is at https://alivecor.com.
Six leads, six times the heart data of its competitors. Record an EKG anytime, anywhere. KardiaMobile 6L is portable and works wherever you are and get results in just 30 seconds. It is FDA-cleared and doctor recommended. The clinically validated 6-lead personal EKG, FDA-cleared to detect AFib, Bradycardia, and Tachycardia. Save your EKGs on your phone or send them to your doctor for review remotely. Compatible with most Android and iOS smartphones and tablets.
In this episode, we are going to talk about the new AliveCor’s KardiaMobile 6L Heart Monitor and the accompanying iPhone application, Kardia. The website is at www.AliveCor.com and iPhone application can be found in the Apple App Store.
AliveCor’s new MobileKardia 6L provides a 6-lead EKG monitoring capability.The KardiaMobile Single Lead Device is capable of detecting Atrial Fibrillation, Bradycardia, Tachycardia or normal heart rhythm.iPhone Kardia 6L iPhone App Screenshots
